Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surrozen (SRZN) Capital Expenditures (2021 - 2025)

Surrozen (SRZN) has 5 years of Capital Expenditures data on record, last reported at $24000.0 in Q3 2025.

  • For Q3 2025, Capital Expenditures changed N/A year-over-year to $24000.0; the TTM value through Sep 2025 reached $71000.0, up 914.29%, while the annual FY2024 figure was $9000.0, 97.74% down from the prior year.
  • Capital Expenditures reached $24000.0 in Q3 2025 per SRZN's latest filing, up from $18000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.1 million in Q4 2021 and bottomed at -$495000.0 in Q4 2022.
  • Average Capital Expenditures over 5 years is $130714.3, with a median of $44500.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: plummeted 146.65% in 2022, then skyrocketed 285.71% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $1.1 million in 2021, then tumbled by 146.65% to -$495000.0 in 2022, then surged by 163.23% to $313000.0 in 2023, then tumbled by 99.36% to $2000.0 in 2024, then skyrocketed by 1100.0% to $24000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $24000.0 in Q3 2025, $18000.0 in Q2 2025, and $27000.0 in Q1 2025.